Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:diseases:co-infections [06.07.2011] paulalberthome:diseases:co-infections [06.07.2011] paulalbert
Line 18: Line 18:
  
  
-===== Marshall Protocol targets co-infections =====+===== Marshall Protocol targets "co-infections=====
  
 <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article> <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article>
  
-Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes – including and especially co-infections. One component of the innate immune response is the antimicrobial peptides.+Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including "co-infections.One important component of the innate immune response is the antimicrobial peptides. 
  
 {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}} {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}}
home/diseases/co-infections.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.